This suggests that periplakin may be useful as a biomarker for diagnosing early esophageal cancer.[79] Studies have also indicated a strong association between MACF1 with gastric cancer stage and metastasis, suggesting it as a potential prognostic biomarker. This evidence concerns the gene MACF1 and gastric cancer.